These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12435898)

  • 1. Osteoporosis and the growth hormone-insulin-like growth factor axis.
    Geusens PP; Boonen S
    Horm Res; 2002; 58 Suppl 3():49-55. PubMed ID: 12435898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anabolic effects of GH/IGF system on bone.
    Kasukawa Y; Miyakoshi N; Mohan S
    Curr Pharm Des; 2004; 10(21):2577-92. PubMed ID: 15320746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GH and IGF-I as therapeutic agents for osteoporosis.
    Agnusdei D; Gentilella R
    J Endocrinol Invest; 2005; 28(8 Suppl):32-6. PubMed ID: 16323827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormones and osteoporosis update. Growth hormone and bone].
    Tanaka H
    Clin Calcium; 2009 Jul; 19(7):984-9. PubMed ID: 19567995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis.
    Johansson AG; Lindh E; Blum WF; Kollerup G; Sørensen OH; Ljunghall S
    J Clin Endocrinol Metab; 1996 Jan; 81(1):44-8. PubMed ID: 8550792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fetal programming of the growth hormone-insulin-like growth factor axis.
    Holt RI
    Trends Endocrinol Metab; 2002 Nov; 13(9):392-7. PubMed ID: 12367821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis.
    Eriksen EF; Kassem M; Brixen K
    Horm Res; 1993; 40(1-3):95-8. PubMed ID: 8300056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical review 123: Anabolic therapy for osteoporosis.
    Rosen CJ; Bilezikian JP
    J Clin Endocrinol Metab; 2001 Mar; 86(3):957-64. PubMed ID: 11238469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human growth hormone as potential therapy for osteoporosis.
    Marcus R
    Baillieres Clin Endocrinol Metab; 1998 Jul; 12(2):251-60. PubMed ID: 10083895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal effects of growth hormone and insulin-like growth factor-I therapy.
    Lindsey RC; Mohan S
    Mol Cell Endocrinol; 2016 Sep; 432():44-55. PubMed ID: 26408965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Male osteoporosis: current treatments and future options].
    Romagnoli E; Paglia F; Dionisi S; De Geronimo S; Pepe J; Di Virgilio R; Minisola S
    Clin Ter; 2003; 154(1):49-53. PubMed ID: 12854284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on growth hormone (GH) and the insulin-like growth factors (IGFs).
    Le Roith D; Sonksen PH
    Growth Horm IGF Res; 1998 Feb; 8(1):1-2. PubMed ID: 10990438
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone, insulin-like growth factors, and the senescent skeleton: Ponce de Leon's Fountain revisited?
    Rosen CJ
    J Cell Biochem; 1994 Nov; 56(3):348-56. PubMed ID: 7876328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
    Marie PJ; Kassem M
    Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological and clinical importance of insulin-like growth factor-I with respect to bone metabolism.
    Zofková I
    Physiol Res; 2003; 52(6):657-79. PubMed ID: 14640888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anabolic therapy of osteoporosis].
    Fernández-García D; Alonso G; Muñoz-Torres M
    Med Clin (Barc); 2005 Sep; 125(9):341-5. PubMed ID: 16185635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone metabolism in relation to alterations in systemic growth hormone.
    Ueland T
    Growth Horm IGF Res; 2004 Dec; 14(6):404-17. PubMed ID: 15519248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, insulin-like growth factors and bone remodelling.
    Eriksen EF; Kassem M; Langdahl B
    Eur J Clin Invest; 1996 Jul; 26(7):525-34. PubMed ID: 8864413
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatopause: dismetabolic and bone effects.
    Lombardi G; Tauchmanova L; Di Somma C; Musella T; Rota F; Savanelli MC; Colao A
    J Endocrinol Invest; 2005; 28(10 Suppl):36-42. PubMed ID: 16550721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic steroid therapies for growth disorders.
    Rogol AD
    Hosp Pract (Off Ed); 1989 Nov; 24(11):89-92, 97-100, 103-6. PubMed ID: 2509505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.